Brief: Granules India Gets ANDA Approval For Colchicine Capsules
30/04/2024 05:42
April 30 (Reuters) - Granules India Ltd GRAN.NS :
* RECEIPT OF ANDA APPROVAL FOR COLCHICINE CAPSULES
* US FDA APPROVED ANDA FILED BY UNIT GRANULES
PHARMACEUTICALS, INC
FOR COLCHICINE CAPSULES
Source text for Eikon: ID:nBSE4HM7xD
Further company coverage: GRAN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake